Anabolic resistance in critically ill patients

Area of Science:

• Muscle physiology
• Critical care medicine
• Gerontology

Background:

• Critically ill patients often experience muscle loss because protein synthesis cannot outpace protein breakdown.
• Aging and immobility contribute to muscle wasting by affecting protein turnover and anabolic signaling.
• Anabolic resistance, characterized by reduced muscle protein synthesis and impaired insulin response, is a key factor in age-related muscle loss.

Purpose of the Study:

• To investigate the mechanisms of muscle loss in critically ill patients, focusing on the roles of aging and immobility.
• To elucidate the concept of anabolic resistance in the context of aging and immobility.
• To understand how immobility affects muscle protein synthesis and response to amino acid infusion.

Main Methods:

• The study reviews existing literature on protein metabolism, aging, immobility, and critical illness.
• It analyzes the impact of hormonal and cytokine environments on protein breakdown.
• It examines age-related changes in muscle protein synthesis capacity (RNA/DNA) and signaling pathways.

Main Results:

• Aging reduces muscle's ability to incorporate amino acids into protein due to decreased synthesis capacity and signaling sensitivity.
• Older adults exhibit insulin resistance in muscle, impairing the inhibition of protein breakdown.
• Immobility decreases muscle protein synthesis without increasing breakdown and blunts the response to amino acid infusion.

Conclusions:

• Anabolic resistance, a combination of impaired protein synthesis and insulin resistance, contributes significantly to muscle wasting in older, critically ill, or immobilized individuals.
• Immobility exacerbates muscle protein loss by reducing synthesis capacity and responsiveness to nutrients.
• Strategies to combat muscle loss must address both aging-related anabolic resistance and the effects of immobility.